PAI-1 is the primary physiologic inhibitor of urokinase-type plasminogen activator （uPA） and tissue-type plasminogen activator （tPA） and plays important roles in a number of physiologic processes including fibrino...PAI-1 is the primary physiologic inhibitor of urokinase-type plasminogen activator （uPA） and tissue-type plasminogen activator （tPA） and plays important roles in a number of physiologic processes including fibrinolysis, angiogenesis, wound healing, and cell migration. PAI-1 has been proposed as a potential target for inhibitor development and many inhibitors have been reported. However, little was known about the inhibitory mechanism of these inhibitors. Here we determine the crystal structure of PAI-1 in complex with a reported inhibitor, sodium gallate. The PAI-1 ：gallate structure shows that gallate inserts into the cavity formed by helix D, helix E, helix F and t-strand 2A. This work provides insights into the inhibitory mechanism of gallate and lays out structural basis for further PAI-I inhibitor design.展开更多
基金Supported by the National Natural Science Foundation of China (31161130356, 30770429)
文摘PAI-1 is the primary physiologic inhibitor of urokinase-type plasminogen activator （uPA） and tissue-type plasminogen activator （tPA） and plays important roles in a number of physiologic processes including fibrinolysis, angiogenesis, wound healing, and cell migration. PAI-1 has been proposed as a potential target for inhibitor development and many inhibitors have been reported. However, little was known about the inhibitory mechanism of these inhibitors. Here we determine the crystal structure of PAI-1 in complex with a reported inhibitor, sodium gallate. The PAI-1 ：gallate structure shows that gallate inserts into the cavity formed by helix D, helix E, helix F and t-strand 2A. This work provides insights into the inhibitory mechanism of gallate and lays out structural basis for further PAI-I inhibitor design.
